Amicus Therapeutics
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Option
GERSHKOWITZ JAYNE officer: SVP, Chief Patient Adv..
Common stock 10,648 $11.51 $122,569
Option
GERSHKOWITZ JAYNE officer: SVP, Chief Patient Adv..
Stock Options (right to buy) 10,648 $1.18 $12,533
Option
BAIRD WILLIAM D III officer: Chief Financial Officer
Common stock 15,235 $8.85 $134,784
Option
BAIRD WILLIAM D III officer: Chief Financial Officer
Stock options (right to buy) 7,500 $11.51 $86,295
Sale
CROWLEY JOHN F director, officer: Chairman & CEO
Common Stock 268,322 $5.33 $1,428,815
Option
VALENZANO KEN officer: SVP, Pharmacology & Bi..
Stock Options (right to buy) 16,550 $0.7 $11,635
Option
BAIRD WILLIAM D III officer: Chief Financial Officer
Stock Options (right to buy) 7,735 $7.52 $58,152
Option
CROWLEY JOHN F director, officer: Chairman & CEO
Stock Options (right to buy) 268,322 $5.33 $1,428,815
Option
CAMPBELL BRADLEY L director, officer: Chief Operat..
Stock Options (right to buy) 12,583 $4.16 $52,345
Option
CAMPBELL BRADLEY L director, officer: Chief Operat..
Stocl Options (right to buy) 416 $11.51 $4,787
Option
VALENZANO KEN officer: SVP, Pharmacology & Bi..
Common stock 19,093 $11.6 $221,555
Sale
GERSHKOWITZ JAYNE officer: SVP, Chief Patient Adv..
Common stock 10,648 $11.51 $122,569
Option
DILONE ENRIQUE officer: SVP, Technical Operati..
Common stock 14,045 $11.51 $161,672
Option
DILONE ENRIQUE officer: SVP, Technical Operati..
Stock Options (right to buy) 14,045 $0.83 $11,685
Option
PEIST KENNETH officer: VP, Legal & IP
Common stock 10,000 $11.52 $115,160
Option
CASTELLI JEFF officer: SVP, Program Management
Stock Options (right to buy) 4,667 $5.33 $24,852
Sale
CASTELLI JEFF officer: SVP, Program Management
Common stock 4,667 $5.33 $24,852
Option
CASTELLI JEFF officer: SVP, Program Management
Common stock 4,667 $5.33 $24,852
Option
CROWLEY JOHN F director, officer: Chairman & CEO
Stock Options (right to buy) 89,000 $5.33 $473,925
Sale
CROWLEY JOHN F director, officer: Chairman & CEO
Common Stock 89,000 $5.33 $473,925
Purchase
CROWLEY JOHN F director, officer: Chairman & CEO
Common Stock 89,000 $5.33 $473,925
Sale
BAIRD WILLIAM D III officer: Chief Financial Officer
Common stock 10,000 $3.53 $35,300
Purchase
PEIST KENNETH officer: VP, Legal & IP
Common stock 4,500 $4.16 $18,720
Purchase
VALENZANO KEN officer: SVP, Pharmacology & Bi..
Common stock 25,000 $4.54 $113,500
Option
VALENZANO KEN officer: SVP, Pharmacology & Bi..
Stock Options (right to buy) 25,000 $4.54 $113,500
Sale
QUIMI DAPHNE officer: Chief Financial Officer
Common stock 3,500 $4.16 $14,560
Option
QUIMI DAPHNE officer: Chief Financial Officer
Stock Options (right to buy) 3,500 $4.16 $14,560
Sale
VALENZANO KEN officer: SVP, Pharmacology & Bi..
Common stock 25,000 $8 $200,000
Sale
CAMPBELL BRADLEY L director, officer: Chief Operat..
Common stock 7,250 $4.16 $30,160
Purchase
CAMPBELL BRADLEY L director, officer: Chief Operat..
Common stock 7,250 $4.16 $30,160
Option
DILONE ENRIQUE officer: SVP, Technical Operati..
Stock Options (right to buy) 7,000 $4.16 $29,120
Sale
CASTELLI JEFF officer: SVP, Program Management
Common stock 8,103 $3.53 $28,604
Purchase
CASTELLI JEFF officer: SVP, Program Management
Common stock 8,103 $3.53 $28,604
Option
BAIRD WILLIAM D III officer: Chief Financial Officer
Stock Options (right to buy) 10,000 $3.53 $35,300
Option
CAMPBELL BRADLEY L director, officer: Chief Operat..
Stock Options (right to buy) 7,250 $4.16 $30,160
Option
CASTELLI JEFF officer: SVP, Program Management
Stock Options (right to buy) 8,103 $3.53 $28,604
Purchase
BAIRD WILLIAM D III officer: Chief Financial Officer
Common stock 10,000 $3.53 $35,300
Option
PEIST KENNETH officer: VP, Legal & IP
Stock Options (right to buy) 4,500 $4.16 $18,720
Sale
PEIST KENNETH officer: VP, Legal & IP
Common stock 4,500 $4.16 $18,720
Purchase
QUIMI DAPHNE officer: Chief Financial Officer
Common stock 3,500 $4.16 $14,560
Purchase
DILONE ENRIQUE officer: SVP, Technical Operati..
Common stock 7,000 $4.16 $29,120
Sale
DILONE ENRIQUE officer: SVP, Technical Operati..
Common srock 7,000 $4.16 $29,120
Purchase
PERCEPTIVE ADVISORS LLC 10 percent owner
Common Stock 2,100,000 $6.5 $13,650,000
Sale
GLAXOSMITHKLINE PLC other: Former 10% Owner (1)
Common Stock 11,315,825 $5.29 $59,872,030
Option
BAIRD WILLIAM D III officer: Chief Financial Officer
Stock Options (right to buy) 10,000 $3.53 $35,300
Sale
PEIST KENNETH officer: VP, Legal & IP
Common stock 13,853 $3.53 $48,901
Option
QUIMI DAPHNE officer: Chief Financial Officer
Stock Options (right to buy) 6,812 $1.77 $12,023
Sale
BAIRD WILLIAM D III officer: Chief Financial Officer
Common stock 10,000 $3.53 $35,300
Purchase
PEIST KENNETH officer: VP, Legal & IP
Common stock 13,853 $3.53 $48,901
Purchase
QUIMI DAPHNE officer: Chief Financial Officer
Common stock 6,812 $7 $47,684

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.